Quest Diagnostics (DGX)
NYSE: DGX
· Real-Time Price · USD
179.75
1.31 (0.73%)
At close: Aug 15, 2025, 3:59 PM
182.00
1.25%
After-hours: Aug 15, 2025, 04:48 PM EDT
Quest Diagnostics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 319M | 188M | 549M | 764M | 271M | 474M | 686M | 143M | 126M | 175M | 315M | 700M | 790M | 712M | 872M | 987M | 560M | 1.23B |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 136M | 134M | 123M | 125M | 126M | 133M | 135M | 130M | 135M | 128M | 132M | 138M | 147M | 155M | 141M | 124M | 111M | 527M |
Other Long-Term Assets | 271M | 260M | 255M | 272M | 216M | 182M | 198M | 149M | 152M | 150M | 144M | 132M | 137M | 155M | 163M | 155M | 176M | 170M |
Receivables | 1.42B | 1.4B | 1.3B | 1.38B | 1.32B | 1.32B | 1.21B | 1.28B | 1.24B | 1.25B | 1.2B | 1.28B | 1.29B | 1.37B | 1.44B | 1.47B | 1.25B | 1.38B |
Inventory | 187M | 189M | 188M | 184M | 182M | 181M | 190M | 184M | 184M | 190M | 192M | 183M | 187M | 197M | 208M | 205M | 199M | 223M |
Other Current Assets | 273M | 294M | 351M | 299M | 245M | 251M | 286M | 207M | 188M | 195M | 196M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 2.2B | 2.08B | 2.39B | 2.62B | 2.02B | 2.23B | 2.37B | 1.81B | 1.73B | 1.81B | 1.9B | 2.33B | 2.43B | 2.48B | 2.74B | 2.85B | 2.15B | 3B |
Property-Plant & Equipment | 2.77B | 2.75B | 2.76B | 2.75B | 2.44B | 2.39B | 2.42B | 2.44B | 2.42B | 2.38B | 2.35B | 2.31B | 2.26B | 2.29B | 2.3B | 2.23B | 2.21B | 2.22B |
Goodwill & Intangibles | 10.59B | 10.57B | 10.62B | 10.32B | 9.09B | 9.02B | 8.9B | 8.95B | 8.98B | 8.32B | 8.31B | 8.3B | 8.34B | 8.37B | 8.26B | 8.21B | 8.22B | 8.01B |
Total Long-Term Assets | 13.77B | 13.72B | 13.76B | 13.47B | 11.86B | 11.73B | 11.65B | 11.67B | 11.69B | 10.98B | 10.94B | 10.89B | 10.89B | 10.97B | 10.87B | 10.72B | 10.71B | 10.93B |
Total Assets | 15.97B | 15.8B | 16.15B | 16.09B | 13.88B | 13.95B | 14.02B | 13.48B | 13.43B | 12.79B | 12.84B | 13.22B | 13.31B | 13.44B | 13.61B | 13.57B | 12.86B | 13.93B |
Account Payables | 1.35B | 1.25B | 1.39B | 1.27B | 1.2B | 1.19B | 1.35B | 1.14B | 1.18B | 1.16B | 1.4B | 1.45B | 1.42B | 1.54B | 1.6B | 1.61B | 1.4B | 1.56B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 675M | 174M | 775M | 779M | 765M | 1.06B | 456M | 461M | 674M | 157M | 155M | 155M | 157M | 156M | 153M | 149M | 147M | 148M |
Other Current Liabilities | n/a | 20M | 5M | 44M | 44M | 47M | 5M | 14M | 25M | 43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 2.02B | 1.44B | 2.17B | 2.09B | 2.01B | 2.3B | 1.81B | 1.62B | 1.88B | 1.35B | 1.55B | 1.6B | 1.58B | 1.7B | 1.75B | 1.76B | 1.55B | 1.71B |
Long-Term Debt | 5.17B | 5.86B | 5.6B | 5.65B | 3.82B | 3.8B | 4.41B | 3.95B | 3.78B | 3.98B | 3.98B | 3.98B | 3.98B | 3.98B | 4.01B | 4.01B | 4.01B | 4.01B |
Other Long-Term Liabilities | 890M | 917M | 688M | 891M | 811M | 817M | 606M | 874M | 901M | 809M | 517M | 787M | 728M | 742M | 502M | 801M | 792M | 842M |
Total Long-Term Liabilities | 6.6B | 7.31B | 7.09B | 7.08B | 5.13B | 5.11B | 5.79B | 5.33B | 5.19B | 5.27B | 5.28B | 5.27B | 5.21B | 5.25B | 5.3B | 5.3B | 5.29B | 5.36B |
Total Liabilities | 8.62B | 8.75B | 9.26B | 9.17B | 7.15B | 7.41B | 7.6B | 6.94B | 7.06B | 6.63B | 6.83B | 6.87B | 6.79B | 6.95B | 7.05B | 7.06B | 6.84B | 7.06B |
Total Debt | 6.38B | 6.57B | 6.92B | 6.97B | 5.09B | 5.35B | 5.37B | 4.91B | 4.96B | 4.62B | 4.62B | 4.64B | 4.64B | 4.66B | 4.66B | 4.65B | 4.65B | 4.66B |
Common Stock | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M |
Retained Earnings | 9.68B | 9.49B | 9.36B | 9.22B | 9.08B | 8.94B | 8.82B | 8.71B | 8.57B | 8.41B | 8.29B | 8.26B | 8.08B | 7.93B | 7.65B | 7.33B | 10.25B | 9.69B |
Comprehensive Income | -16M | -83M | -88M | -15M | -19M | -16M | -14M | -20M | -16M | -18M | -21M | -31M | -23M | -16M | -14M | -13M | -10M | -31M |
Shareholders Equity | 7.23B | 6.93B | 6.78B | 6.81B | 6.62B | 6.43B | 6.31B | 6.42B | 6.25B | 6.05B | 5.89B | 6.24B | 6.41B | 6.38B | 6.44B | 6.39B | 5.9B | 6.75B |
Total Investments | 136M | 134M | 123M | 125M | 126M | 133M | 135M | 130M | 135M | 128M | 132M | 138M | 147M | 155M | 141M | 124M | 111M | 527M |